Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 288 entries
Sorted by: Best Match Show Resources per page
Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort.

Clinical epidemiology

Jensvoll H, Severinsen MT, Hammerstrøm J, Brækkan SK, Kristensen SR, Cannegieter SC, Blix K, Tjønneland A, Rosendaal FR, Dziewiecka O, Overvad K, Næss IA, Hansen JB.
PMID: 26396546
Clin Epidemiol. 2015 Sep 16;7:401-10. doi: 10.2147/CLEP.S84279. eCollection 2015.

BACKGROUND: Although venous thromboembolism (VTE) is a known common complication in cancer patients, there is limited knowledge on patient-related and cancer-specific risk factors in the general population. The Scandinavian Thrombosis and Cancer (STAC) Cohort was established by merging individual...

Cite
Jensvoll H, Severinsen MT, Hammerstrøm J, et al. Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort. Clin Epidemiol. 2015;7:401-10doi: 10.2147/CLEP.S84279.
Jensvoll, H., Severinsen, M. T., Hammerstrøm, J., Brækkan, S. K., Kristensen, S. R., Cannegieter, S. C., Blix, K., Tjønneland, A., Rosendaal, F. R., Dziewiecka, O., Overvad, K., Næss, I. A., & Hansen, J. B. (2015). Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort. Clinical epidemiology, 7401-10. https://doi.org/10.2147/CLEP.S84279
Jensvoll, Hilde, et al. "Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort." Clinical epidemiology vol. 7 (2015): 401-10. doi: https://doi.org/10.2147/CLEP.S84279
Jensvoll H, Severinsen MT, Hammerstrøm J, Brækkan SK, Kristensen SR, Cannegieter SC, Blix K, Tjønneland A, Rosendaal FR, Dziewiecka O, Overvad K, Næss IA, Hansen JB. Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort. Clin Epidemiol. 2015 Sep 16;7:401-10. doi: 10.2147/CLEP.S84279. eCollection 2015. PMID: 26396546; PMCID: PMC4577261.
Copy Download .nbib Format: NLM
Translation and adaptation of the Child Posttraumatic Cognitions Inventory (cPTCI) to Brazilian Portuguese.

Trends in psychiatry and psychotherapy

Lobo Bde O, Brunnet AE, Silva TL, Santos LM, Gauer G, Arteche AX, Kristensen CH.
PMID: 27000710
Trends Psychiatry Psychother. 2014 Jun;36(2):107-12. doi: 10.1590/2237-6089-2014-1002.

INTRODUCTION: Experiencing a traumatic event is a risk factor for the development of mental illness, especially posttraumatic stress disorder. A child's appraisals of a traumatic event may play a prominent role in the development or maintenance of the disorder....

Cite
Lobo Bde O, Brunnet AE, Silva TL, et al. Translation and adaptation of the Child Posttraumatic Cognitions Inventory (cPTCI) to Brazilian Portuguese. Trends Psychiatry Psychother. 2014;36(2):107-12doi: 10.1590/2237-6089-2014-1002.
Lobo, B. d. e. . O., Brunnet, A. E., Silva, T. L., Santos, L. M., Gauer, G., Arteche, A. X., & Kristensen, C. H. (2014). Translation and adaptation of the Child Posttraumatic Cognitions Inventory (cPTCI) to Brazilian Portuguese. Trends in psychiatry and psychotherapy, 36(2), 107-12. https://doi.org/10.1590/2237-6089-2014-1002
Lobo, Beatriz de Oliveira Meneguelo, et al. "Translation and adaptation of the Child Posttraumatic Cognitions Inventory (cPTCI) to Brazilian Portuguese." Trends in psychiatry and psychotherapy vol. 36,2 (2014): 107-12. doi: https://doi.org/10.1590/2237-6089-2014-1002
Lobo Bde O, Brunnet AE, Silva TL, Santos LM, Gauer G, Arteche AX, Kristensen CH. Translation and adaptation of the Child Posttraumatic Cognitions Inventory (cPTCI) to Brazilian Portuguese. Trends Psychiatry Psychother. 2014 Jun;36(2):107-12. doi: 10.1590/2237-6089-2014-1002. PMID: 27000710.
Copy Download .nbib Format: NLM
Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.

Fluids and barriers of the CNS

Malm J, Graff-Radford NR, Ishikawa M, Kristensen B, Leinonen V, Mori E, Owler BK, Tullberg M, Williams MA, Relkin NR.
PMID: 23758953
Fluids Barriers CNS. 2013 Jun 10;10(1):22. doi: 10.1186/2045-8118-10-22.

Idiopathic normal pressure hydrocephalus (INPH) is a syndrome of ventriculomegaly, gait impairment, cognitive decline and incontinence that occurs in an elderly population prone to many types of comorbidities. Identification of the comorbidities is thus an important part of the...

Cite
Malm J, Graff-Radford NR, Ishikawa M, et al. Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS. 2013;10(1):22doi: 10.1186/2045-8118-10-22.
Malm, J., Graff-Radford, N. R., Ishikawa, M., Kristensen, B., Leinonen, V., Mori, E., Owler, B. K., Tullberg, M., Williams, M. A., & Relkin, N. R. (2013). Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids and barriers of the CNS, 10(1), 22. https://doi.org/10.1186/2045-8118-10-22
Malm, Jan, et al. "Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH." Fluids and barriers of the CNS vol. 10,1 (2013): 22. doi: https://doi.org/10.1186/2045-8118-10-22
Malm J, Graff-Radford NR, Ishikawa M, Kristensen B, Leinonen V, Mori E, Owler BK, Tullberg M, Williams MA, Relkin NR. Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS. 2013 Jun 10;10(1):22. doi: 10.1186/2045-8118-10-22. PMID: 23758953; PMCID: PMC3689166.
Copy Download .nbib Format: NLM
Deliver the drug and be resorbed: evidence from ABSORB Japan.

European heart journal

Kristensen SD, Christiansen EH, Maeng M.
PMID: 26330418
Eur Heart J. 2015 Dec 14;36(47):3343-5. doi: 10.1093/eurheartj/ehv459. Epub 2015 Sep 01.

No abstract available.

Cite
Kristensen SD, Christiansen EH, Maeng M. Deliver the drug and be resorbed: evidence from ABSORB Japan. Eur Heart J. 2015;36(47):3343-5doi: 10.1093/eurheartj/ehv459.
Kristensen, S. D., Christiansen, E. H., & Maeng, M. (2015). Deliver the drug and be resorbed: evidence from ABSORB Japan. European heart journal, 36(47), 3343-5. https://doi.org/10.1093/eurheartj/ehv459
Kristensen, Steen D, et al. "Deliver the drug and be resorbed: evidence from ABSORB Japan." European heart journal vol. 36,47 (2015): 3343-5. doi: https://doi.org/10.1093/eurheartj/ehv459
Kristensen SD, Christiansen EH, Maeng M. Deliver the drug and be resorbed: evidence from ABSORB Japan. Eur Heart J. 2015 Dec 14;36(47):3343-5. doi: 10.1093/eurheartj/ehv459. Epub 2015 Sep 01. PMID: 26330418.
Copy Download .nbib Format: NLM
Expansion of HIV/AIDS in China: lessons from Yunnan Province.

Social science & medicine (1982)

Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH.
PMID: 17107739
Soc Sci Med. 2007 Feb;64(3):665-75. doi: 10.1016/j.socscimed.2006.09.019. Epub 2006 Nov 14.

In this article we systematically and critically review the Chinese and English language literature on human immunodeficiency virus (HIV)-related studies in Yunnan Province, Southwestern China. Yunnan Province had the first Chinese HIV outbreak and is still the worst affected...

Cite
Xiao Y, Kristensen S, Sun J, et al. Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med. 2006;64(3):665-75doi: 10.1016/j.socscimed.2006.09.019.
Xiao, Y., Kristensen, S., Sun, J., Lu, L., & Vermund, S. H. (2007). Expansion of HIV/AIDS in China: lessons from Yunnan Province. Social science & medicine (1982), 64(3), 665-75. https://doi.org/10.1016/j.socscimed.2006.09.019
Xiao, Yan, et al. "Expansion of HIV/AIDS in China: lessons from Yunnan Province." Social science & medicine (1982) vol. 64,3 (2007): 665-75. doi: https://doi.org/10.1016/j.socscimed.2006.09.019
Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH. Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med. 2007 Feb;64(3):665-75. doi: 10.1016/j.socscimed.2006.09.019. Epub 2006 Nov 14. PMID: 17107739; PMCID: PMC2730760.
Copy Download .nbib Format: NLM
Veterinary cancer registries in companion animal cancer: a review.

Veterinary and comparative oncology

Brønden LB, Flagstad A, Kristensen AT.
PMID: 19754785
Vet Comp Oncol. 2007 Sep;5(3):133-44. doi: 10.1111/j.1476-5829.2007.00126.x.

Current and prior veterinary cancer registries are few in number and scattered. Different inclusion criteria, dissimilar collection methods and variable reference population estimation methods pose obstacles in the comparisons between veterinary and human cancer registries. Veterinary cancer registries have...

Cite
Brønden LB, Flagstad A, Kristensen AT. Veterinary cancer registries in companion animal cancer: a review. Vet Comp Oncol. 2007;5(3):133-44doi: 10.1111/j.1476-5829.2007.00126.x.
Brønden, L. B., Flagstad, A., & Kristensen, A. T. (2007). Veterinary cancer registries in companion animal cancer: a review. Veterinary and comparative oncology, 5(3), 133-44. https://doi.org/10.1111/j.1476-5829.2007.00126.x
Brønden, L B, et al. "Veterinary cancer registries in companion animal cancer: a review." Veterinary and comparative oncology vol. 5,3 (2007): 133-44. doi: https://doi.org/10.1111/j.1476-5829.2007.00126.x
Brønden LB, Flagstad A, Kristensen AT. Veterinary cancer registries in companion animal cancer: a review. Vet Comp Oncol. 2007 Sep;5(3):133-44. doi: 10.1111/j.1476-5829.2007.00126.x. PMID: 19754785.
Copy Download .nbib Format: NLM
Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Christiansen EH, Lassen JF, Andersen HR, Krusell LR, Kristensen SD, Bøtker HE, Thuesen L.
PMID: 19755214
EuroIntervention. 2006 Feb;1(4):403-8.

AIM: Percutaneous coronary intervention (PCI) of left main (LM) coronary artery stenosis may become an alternative to the standard therapy, coronary artery bypass graft surgery (CABG). The purpose of the present study was to describe the outcome after LM...

Cite
Christiansen EH, Lassen JF, Andersen HR, et al. Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients. EuroIntervention. 2006;1(4):403-8
Christiansen, E. H., Lassen, J. F., Andersen, H. R., Krusell, L. R., Kristensen, S. D., Bøtker, H. E., & Thuesen, L. (2006). Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(4), 403-8.
Christiansen, Evald Høj, et al. "Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 1,4 (2006): 403-8.
Christiansen EH, Lassen JF, Andersen HR, Krusell LR, Kristensen SD, Bøtker HE, Thuesen L. Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients. EuroIntervention. 2006 Feb;1(4):403-8. PMID: 19755214.
Copy Download .nbib Format: NLM
Dipyridamole and Platelet Release of Platelet-derived Growth Factor.

Platelets

Vissinger H, Husted SE, Kristensen SD, Nielsen HK.
PMID: 21043611
Platelets. 1994;5(2):105-8. doi: 10.3109/09537109409005520.

Platelet-derived growth factor (PDGF) and β-thromboglobulin (β-TG) are released from platelet alpha-granules during platelet activation. PDGF is a potent chemoattractant and mitogen for human vascular smooth muscle cells, and may be important in the development of late restenosis following...

Cite
Vissinger H, Husted SE, Kristensen SD, et al. Dipyridamole and Platelet Release of Platelet-derived Growth Factor. Platelets. 1994;5(2):105-8doi: 10.3109/09537109409005520.
Vissinger, H., Husted, S. E., Kristensen, S. D., & Nielsen, H. K. (1994). Dipyridamole and Platelet Release of Platelet-derived Growth Factor. Platelets, 5(2), 105-8. https://doi.org/10.3109/09537109409005520
Vissinger, H, et al. "Dipyridamole and Platelet Release of Platelet-derived Growth Factor." Platelets vol. 5,2 (1994): 105-8. doi: https://doi.org/10.3109/09537109409005520
Vissinger H, Husted SE, Kristensen SD, Nielsen HK. Dipyridamole and Platelet Release of Platelet-derived Growth Factor. Platelets. 1994;5(2):105-8. doi: 10.3109/09537109409005520. PMID: 21043611.
Copy Download .nbib Format: NLM
Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

American journal of cardiovascular disease

Moura LM, Faria S, Brito M, Pinto FJ, Kristensen SD, Barros IM, Rajamannan N, Rocha-Gonçalves F.
PMID: 22720202
Am J Cardiovasc Dis. 2012;2(2):123-32. Epub 2012 May 15.

INTRODUCTION AND OBJECTIVES: Paraoxonases may exert anti-atherogenic action by reducing lipid peroxidation. Previous studies examined associations between polymorphisms in the paraoxonase 1 (PON1) gene and development of coronary artery disease (CAD), with inconsistent results. Given the similarities in clinical...

Cite
Moura LM, Faria S, Brito M, et al. Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis. Am J Cardiovasc Dis. 2012;2(2):123-32
Moura, L. M., Faria, S., Brito, M., Pinto, F. J., Kristensen, S. D., Barros, I. M., Rajamannan, N., & Rocha-Gonçalves, F. (2012). Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis. American journal of cardiovascular disease, 2(2), 123-32.
Moura, Luis M, et al. "Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis." American journal of cardiovascular disease vol. 2,2 (2012): 123-32.
Moura LM, Faria S, Brito M, Pinto FJ, Kristensen SD, Barros IM, Rajamannan N, Rocha-Gonçalves F. Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis. Am J Cardiovasc Dis. 2012;2(2):123-32. Epub 2012 May 15. PMID: 22720202; PMCID: PMC3371627.
Copy Download .nbib Format: NLM
Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping.

Journal of extracellular vesicles

Jørgensen M, Bæk R, Pedersen S, Søndergaard EK, Kristensen SR, Varming K.
PMID: 24009888
J Extracell Vesicles. 2013 Jun 18;2. doi: 10.3402/jev.v2i0.20920. eCollection 2013.

BACKGROUND: Exosomes are one of the several types of cell-derived vesicles with a diameter of 30-100 nm. These extracellular vesicles are recognized as potential markers of human diseases such as cancer. However, their use in diagnostic tests requires an...

Cite
Jørgensen M, Bæk R, Pedersen S, et al. Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping. J Extracell Vesicles. 2013;2doi: 10.3402/jev.v2i0.20920.
Jørgensen, M., Bæk, R., Pedersen, S., Søndergaard, E. K., Kristensen, S. R., & Varming, K. (2013). Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping. Journal of extracellular vesicles, 2. https://doi.org/10.3402/jev.v2i0.20920
Jørgensen, Malene, et al. "Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping." Journal of extracellular vesicles vol. 2 (2013). doi: https://doi.org/10.3402/jev.v2i0.20920
Jørgensen M, Bæk R, Pedersen S, Søndergaard EK, Kristensen SR, Varming K. Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping. J Extracell Vesicles. 2013 Jun 18;2. doi: 10.3402/jev.v2i0.20920. eCollection 2013. PMID: 24009888; PMCID: PMC3760630.
Copy Download .nbib Format: NLM
Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study.

Clinical epidemiology

Bruun SB, Petersen I, Kristensen NR, Cronin-Fenton D, Pedersen AB.
PMID: 30214311
Clin Epidemiol. 2018 Aug 27;10:1053-1071. doi: 10.2147/CLEP.S166309. eCollection 2018.

PURPOSE: To examine the association between selective serotonin reuptake inhibitor (SSRI) use and mortality, postoperative complications, and quality of in-hospital care in hip fracture patients.PATIENTS AND METHODS: The study was a nationwide cohort study based on individual-level linked, prospectively...

Cite
Bruun SB, Petersen I, Kristensen NR, et al. Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study. Clin Epidemiol. 2018;10:1053-1071doi: 10.2147/CLEP.S166309.
Bruun, S. B., Petersen, I., Kristensen, N. R., Cronin-Fenton, D., & Pedersen, A. B. (2018). Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study. Clinical epidemiology, 101053-1071. https://doi.org/10.2147/CLEP.S166309
Bruun, Stine Bakkensen, et al. "Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study." Clinical epidemiology vol. 10 (2018): 1053-1071. doi: https://doi.org/10.2147/CLEP.S166309
Bruun SB, Petersen I, Kristensen NR, Cronin-Fenton D, Pedersen AB. Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study. Clin Epidemiol. 2018 Aug 27;10:1053-1071. doi: 10.2147/CLEP.S166309. eCollection 2018. PMID: 30214311; PMCID: PMC6118260.
Copy Download .nbib Format: NLM
A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study.

Pain reports

Mogensen S, Treldal C, Sveinsdottir K, Jensen K, Kristensen CA, Mogensen TS, Petersen J, Andersen O.
PMID: 29392194
Pain Rep. 2016 Sep 30;1(3):e571. doi: 10.1097/PR9.0000000000000571. eCollection 2016 Sep.

No abstract available.

Cite
Mogensen S, Treldal C, Sveinsdottir K, et al. A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study. Pain Rep. 2016;1(3):e571doi: 10.1097/PR9.0000000000000571.
Mogensen, S., Treldal, C., Sveinsdottir, K., Jensen, K., Kristensen, C. A., Mogensen, T. S., Petersen, J., & Andersen, O. (2016). A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study. Pain reports, 1(3), e571. https://doi.org/10.1097/PR9.0000000000000571
Mogensen, Stine, et al. "A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study." Pain reports vol. 1,3 (2016): e571. doi: https://doi.org/10.1097/PR9.0000000000000571
Mogensen S, Treldal C, Sveinsdottir K, Jensen K, Kristensen CA, Mogensen TS, Petersen J, Andersen O. A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study. Pain Rep. 2016 Sep 30;1(3):e571. doi: 10.1097/PR9.0000000000000571. eCollection 2016 Sep. PMID: 29392194; PMCID: PMC5741316.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 288 entries